ITOS - Iteos Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ITOS is currently covered by 1 analysts with an average price target of $23.69. This is a potential upside of $13.54 (133.4%) from yesterday's end of day stock price of $10.15.

Iteos Therapeutics 's activity chart (see below) currently has 15 price targets and 10 ratings on display. The stock rating distribution of ITOS is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.33% with an average time for these price targets to be met of 123.25 days.

Highest price target for ITOS is $9, Lowest price target is $9, average price target is $9.

Most recent stock forecast was given by DAINA GRAYBOSCH from LEERINK on 14-May-2025. First documented stock forecast 17-Aug-2020.

Best performing analysts who are covering ITOS - Iteos Therapeutics :

David Nierengarten Daina Graybosch Swayampakula Ramakanth Christopher Neyor

Currently out of the existing stock ratings of ITOS, 1 are a BUY (50%), 1 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$9

$-1.15 (-11.33%)

$59

4 months 25 days ago
(14-May-2025)

1/3 (33.33%)

$1.4 (18.42%)

14

Buy

$46

4 months 25 days ago
(14-May-2025)

1/10 (10%)

$38.74 (533.61%)

198

Hold

$15

4 months 27 days ago
(12-May-2025)

0/5 (0%)

$7.9 (111.27%)

Buy

$18

$7.85 (77.34%)

$42

1 years 7 months 4 days ago
(05-Mar-2024)

2/4 (50%)

$6.12 (51.52%)

281

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ITOS (Iteos Therapeutics ) average time for price targets to be met?

On average it took 123.25 days on average for the stock forecasts to be realized with a an average price target met ratio 23.33

Which analyst has the current highest performing score on ITOS (Iteos Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the current lower performing score on ITOS (Iteos Therapeutics ) with a proven track record?

CHRISTOPHER NEYOR

Which analyst has the most public recommendations on ITOS (Iteos Therapeutics )?

David Nierengarten works at WEDBUSH and has 8 price targets and 5 ratings on ITOS

Which analyst is the currently most bullish on ITOS (Iteos Therapeutics )?

David Nierengarten with highest potential upside - $7.85

Which analyst is the currently most reserved on ITOS (Iteos Therapeutics )?

Daina Graybosch with lowest potential downside - -$1.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?